Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%
28/09/2026 12:52
BRIEF-Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18% Sept 28 (Reuters) - REDCARE PHARMACY NV RDC.DE:
REDCARE PHARMACY RAISES AGAIN FULL-YEAR 2026 REVENUE GUIDANCE DRIVEN BY STRONG RX MOMENTUM IN GERMANY
REDCARE PHARMACY NV - EXPECTS NON-RX GROWTH OF 10%-12% FOR FULL-YEAR 2026
REDCARE PHARMACY NV - EXPECTS RX REVENUE IN GERMANY EUR 730-760 MILLION, GROWTH OF 45%-51% FOR 2026
REDCARE PHARMACY NV - EXPECTS ADJUSTED EBITDA MARGIN BETWEEN 2.5%-3.0% FOR FULL-YEAR 2026
REDCARE PHARMACY NV - EXPECTS FY TOTAL REVENUE GROWTH OF 16% TO 18%
REDCARE PHARMACY NV - EXPECTS FY RX REVENUE IN GERMANY BETWEEN EUR 730 AND 760 MILLION, REPRESENTING GROWTH OF 45% TO 51%
Source text: ID:nEQ8YkFWna
Further company coverage: RDC.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Redcare Pharmacy NV
See all newsNetherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany
Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
Brief: Redcare Pharmacy Appoints Peter Schmid Von Linstow As CEO
Europe Research Roundup: DEUTZ, Legrand, VAT
Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%